Systematic Estimation of Potential Risk Caused by the Replacement of Aconite’s Cultivar
Yan Shen1★, Sun Xu1, Wang Mengyan1, Tang Yongbin2, Chi Xu3, Honeycutt Hailey3, Tong Kai4, Mou Lan1, Chen Ji1★ Corresponding author
- 1Zhong Weiping, Liu Chen, Mengliang Tian Agricultural College, Sichuan Agricultural University, Wenjiang, Chengdu.
- 2Tibet Vocational Technical College, Chengguan, Lhasa, Tibet.
- 3Cancer Institute, University of Pittsburgh, Pittsburgh, PA, USA.
- 4College of Life Sciences, Sichuan University of Light Industry, Sichuan, China.
CORRESPONDENCE
Yan Shen
Zhong Weiping, Liu Chen, Mengliang Tian Agricultural College, Sichuan Agricultural University, Wenjiang, Chengdu.
Received: 25-03-2019; Revised: 26-04-2019.
Volume 15, Issue 65 · pp. 722–729 · PUBLISHED 19 September 2019 · DOI: 10.4103/pm.pm_136_19
View on Pharmacogn. Mag. original site ↗
ABSTRACT
Background: Aconite is a famous toxic medicinal plant in the world. But in China, the aconite cultivar, Qingchuan cultivar, which has been stably used for 2000 years, are being rapidly replaced by the Liangshan cultivar, a new cultivar with better agronomic traits. However, the risk of the replacement is still unknown. Materials and Methods: We combine field research and cultivation experiments to clarify differences in provenance and differences in agronomic traits. We used high‑performance liquid chromatography (HPLC) to analyze the content of key ingredients in commercially available medicines and semi‑finished drugs. We then performed a transcriptome analysis of the two resources to study the key differential pathways of the two species and conducted a systematic discussion. Statistical Analysis Used: Statistical differences were assessed by analysis of variance or least significant difference. P < 0.05 was considered statistically significant. Results: The survey and cultivation experiments showed that the overwhelming superiority of agronomic traits had already made Liangshan cultivar occupy the vast majority of areas. HPLC showed that the content of diester alkaloids in the Liangshan cultivar was slightly higher and that of higenamine was significantly lower. Analysis of the patented drug and fuzi flake demonstrated a strong correlation between higenamine and cardiac activity. Transcriptome analysis revealed that the upregulation of multiple genes in the isoquinoline pathway in Qingchuan cultivar resulted in the large difference of higenamine.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Shen, Y., Xu, S., Mengyan, W., Yongbin, T., Xu, C., Hailey, H., Kai, T., Lan, M., & Ji, C. (2019). Systematic Estimation of Potential Risk Caused by the Replacement of Aconite’s Cultivar. Pharmacognosy Magazine, 15(65), 722–729. https://doi.org/10.4103/pm.pm_136_19
